Heart Test Laboratories, Inc. (NASDAQ:HSCS – Get Rating) was the recipient of a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 117,300 shares, an increase of 264.3% from the April 30th total of 32,200 shares. Currently, 1.8% of the shares of the company are short sold. Based on an average daily volume of 87,500 shares, the days-to-cover ratio is currently 1.3 days.
Hedge Funds Weigh In On Heart Test Laboratories
Institutional investors have recently made changes to their positions in the stock. Jane Street Group LLC purchased a new stake in shares of Heart Test Laboratories in the second quarter valued at $28,000. Oliver Lagore Vanvalin Investment Group purchased a new stake in shares of Heart Test Laboratories in the third quarter valued at $30,000. Chapin Davis Inc. purchased a new stake in shares of Heart Test Laboratories in the fourth quarter valued at $46,000. AE Wealth Management LLC grew its position in shares of Heart Test Laboratories by 516.8% in the fourth quarter. AE Wealth Management LLC now owns 154,204 shares of the company’s stock valued at $130,000 after purchasing an additional 129,204 shares during the period. Finally, Tradition Wealth Management LLC purchased a new stake in shares of Heart Test Laboratories in the fourth quarter valued at $34,000. 0.82% of the stock is owned by institutional investors and hedge funds.
Heart Test Laboratories Stock Performance
HSCS stock traded down $0.20 during midday trading on Friday, hitting $1.06. 169,928 shares of the stock were exchanged, compared to its average volume of 1,668,625. The stock’s 50-day moving average price is $0.97 and its 200-day moving average price is $1.23. Heart Test Laboratories has a fifty-two week low of $0.71 and a fifty-two week high of $6.00.
Analysts Set New Price Targets
Separately, Ascendiant Capital Markets began coverage on Heart Test Laboratories in a research report on Monday, January 30th. They issued a “buy” rating and a $3.30 target price for the company.
About Heart Test Laboratories
Heart Test Laboratories, Inc, a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information.
- Get a free copy of the StockNews.com research report on Heart Test Laboratories (HSCS)
- Big Lots Becomes A Stomach Churning Value Play
- The Melt-Up In Marvell Is On; But Don’t Chase It Higher
- Is Apple a Growth Stock or a Value Stock?
- Costco’s Earnings Call Reassure Economists, Recession Cancelled
- Hot Inflation, What It Means For The Summer Rally
Receive News & Ratings for Heart Test Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heart Test Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.